{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T20:40:15Z","timestamp":1788640815533,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.ejpb.2013.03.010","type":"journal-article","created":{"date-parts":[[2013,8,16]],"date-time":"2013-08-16T16:14:08Z","timestamp":1376669648000},"page":"26-33","source":"Crossref","is-referenced-by-count":23,"title":["Mechanistic basis for unexpected bioavailability enhancement of polyelectrolyte complexes incorporating BCS class III drugs and carrageenans"],"prefix":"10.1016","volume":"85","author":[{"given":"C.","family":"Heinen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Reuss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Saaler-Reinhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Langguth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2013.03.010_b0005","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1023\/A:1018984731584","article-title":"Intestinal permeability enhancement: efficacy, acute local toxicity, and reversibility","volume":"11","author":"Swenson","year":"1994","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2013.03.010_b0010","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1023\/A:1015000503629","article-title":"Inhibition of P-glycoprotein by D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS)","volume":"16","author":"Dintaman","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2013.03.010_b0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2174\/1567201052772834","article-title":"Intestinal absorption enhancement via the paracellular route by fatty acids, chitosans and others: a target for drug delivery","volume":"2","author":"Cano-Cebrian","year":"2005","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.ejpb.2013.03.010_b0020","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1023\/A:1012160102740","article-title":"Chitosans as absorption enhancers for poorly absorbable drugs 2: mechanism of absorption enhancement","volume":"14","author":"Schipper","year":"1997","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2013.03.010_b0025","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ejps.2009.09.001","article-title":"Evaluation of intestinal absorption enhancement and local mucosal toxicity of two promoters. I. Studies in isolated rat and human colonic mucosae","volume":"38","author":"Maher","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2013.03.010_b0030","first-page":"739","article-title":"Absorption-enhancing mechanism of sodium caprate and decanoylcarnitine in Caco-2 cells","volume":"272","author":"Tomita","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejpb.2013.03.010_b0035","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1023\/A:1020709513562","article-title":"Enhanced permeability of molecular weight markers and poorly bioavailable compounds across Caco-2 cell monolayers using the absorption enhancer, zonula occludens toxin","volume":"19","author":"Cox","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2013.03.010_b0040","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/10611860600613316","article-title":"Zonula occludens toxin synthetic peptide derivative AT1002 enhances in vitro and in vivo intestinal absorption of low molecular weight heparin","volume":"14","author":"Motlekar","year":"2006","journal-title":"J. Drug Target"},{"key":"10.1016\/j.ejpb.2013.03.010_b0045","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.addr.2009.09.006","article-title":"Safety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic","volume":"61","author":"Maher","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2013.03.010_b0050","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/j.addr.2005.07.009","article-title":"Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives","volume":"57","author":"Ugwoke","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2013.03.010_b0055","doi-asserted-by":"crossref","first-page":"108","DOI":"10.2174\/187221108784534126","article-title":"Mucoadhesive polymers for delivery of drugs to the oral cavity","volume":"2","author":"Mizrahi","year":"2008","journal-title":"Recent Pat. Drug Deliv. Formul."},{"key":"10.1016\/j.ejpb.2013.03.010_b0060","doi-asserted-by":"crossref","first-page":"312","DOI":"10.18433\/J3HP41","article-title":"Strategies to prolong the intravaginal residence time of drug delivery systems","volume":"12","author":"Baloglu","year":"2009","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2013.03.010_b0065","doi-asserted-by":"crossref","first-page":"312","DOI":"10.2174\/156720108785914970","article-title":"Mucoadhesive microspheres: a promising tool in drug delivery","volume":"5","author":"Patil","year":"2008","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.ejpb.2013.03.010_b0070","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1211\/jpp.58.8.0002","article-title":"Advances and potential applications of chitosan derivatives as mucoadhesive biomaterials in modern drug delivery","volume":"58","author":"Chopra","year":"2006","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2013.03.010_b0075","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0928-0987(02)00245-2","article-title":"Mucoadhesive and cohesive properties of poly(acrylic acid)-cysteine conjugates with regard to their molecular mass","volume":"18","author":"Leitner","year":"2003","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2013.03.010_b0080","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/mabi.201000388","article-title":"Advances in mucoadhesion and mucoadhesive polymers","volume":"11","author":"Khutoryanskiy","year":"2011","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.ejpb.2013.03.010_b0085","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/0003-9861(53)90421-4","article-title":"Fractionation of carrageenin","volume":"45","author":"Smith","year":"1953","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejpb.2013.03.010_b0090","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2174\/187221109789105658","article-title":"Mucoadhesive vaginal drug delivery systems","volume":"3","author":"Acarturk","year":"2009","journal-title":"Recent Pat. Drug Deliv. Formul."},{"key":"10.1016\/j.ejpb.2013.03.010_b0095","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1208\/s12249-010-9381-4","article-title":"Buccal drug delivery of pravastatin sodium","volume":"11","author":"Shidhaye","year":"2010","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2013.03.010_b0100","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ejpb.2003.12.002","article-title":"Carrageenan-gelatin mucoadhesive systems for ion-exchange based ophthalmic delivery: in vitro and preliminary in vivo studies","volume":"57","author":"Bonferoni","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2013.03.010_b0105","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s12272-012-0217-5","article-title":"The influence of stabilizer and bioadhesive polymer on the permeation-enhancing effect of AT1002 in the nasal delivery of a paracellular marker","volume":"35","author":"Song","year":"2012","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.ejpb.2013.03.010_b0110","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1163\/156856207781554082","article-title":"Novel polyelectrolyte complexes based on poly(methacrylic acid)-bis(2-aminopropyl)poly(ethylene glycol) for oral protein delivery","volume":"18","author":"Sajeesh","year":"2007","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"10.1016\/j.ejpb.2013.03.010_b0115","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/jbm.a.30393","article-title":"Characterization of polyelectrolyte complexes between chondroitin sulfate and chitosan in the solid state","volume":"75","author":"Chen","year":"2005","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.ejpb.2013.03.010_b0120","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jconrel.2006.11.002","article-title":"N-sulfonato-N, O-carboxymethylchitosan: a novel polymeric absorption enhancer for the oral delivery of macromolecules","volume":"117","author":"Thanou","year":"2007","journal-title":"J. Control Release"},{"key":"10.1016\/j.ejpb.2013.03.010_b0125","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ijpharm.2007.05.015","article-title":"Peroral delivery of insulin using chitosan derivatives: a comparative study of polyelectrolyte nanocomplexes and nanoparticles","volume":"342","author":"Jintapattanakit","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2013.03.010_b0130","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2165\/00003088-200544070-00003","article-title":"Clinical pharmacokinetics of trospium chloride","volume":"44","author":"Doroshyenko","year":"2005","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejpb.2013.03.010_b0135","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0939-6411(97)00050-7","article-title":"Intestinal absorption of the quaternary trospium chloride: permeability-lowering factors and bioavailabilities for oral dosage forms","volume":"43","author":"Langguth","year":"1997","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2013.03.010_b0140","first-page":"1362","article-title":"Lipophilisation of hydrophilic compounds. Consequences on transepidermal and intestinal transport of trospium chloride","volume":"37","author":"Langguth","year":"1987","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.ejpb.2013.03.010_b0200","unstructured":"L. Dahne, B. Baude, Method for producing core-shell (CS) particles and microcapsules using porous templates, CS particles and microcapsules, and the use thereof. Patent Capsulution Pharma, 2005. AG PCT\/EP2005\/002810."},{"key":"10.1016\/j.ejpb.2013.03.010_b0150","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1021\/bm701337q","article-title":"Characterization of the epithelial permeation enhancing effect of basic butylated methacrylate copolymer\u2013in vitro studies","volume":"9","author":"Grube","year":"2008","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ejpb.2013.03.010_b0155","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1021\/js970218s","article-title":"Membrane transport of drugs in different regions of the intestinal tract of the rat","volume":"87","author":"Ungell","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2013.03.010_b0160","doi-asserted-by":"crossref","first-page":"7","DOI":"10.14227\/DT150208P7","article-title":"Comparison between dialysis and dispersion methods for in vitro release determination of drugs from multilamellar liposomes","volume":"15","author":"Shazly","year":"2008","journal-title":"Dissolut. Technol."},{"key":"10.1016\/j.ejpb.2013.03.010_b0165","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1023\/A:1012121632357","article-title":"Jejunal permeability: a comparison between the Ussing chamber technique and the single-pass perfusion in humans","volume":"14","author":"Lennernas","year":"1997","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2013.03.010_b0170","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijpharm.2011.02.016","article-title":"Suitability of kappa-carrageenan pellets for the formulation of multiparticulate tablets with modified release","volume":"409","author":"Ghanam","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2013.03.010_b0175","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijpharm.2011.12.034","article-title":"The disintegration behaviour of capsules in fed subjects: a comparison of hypromellose (carrageenan) capsules and standard gelatin capsules","volume":"424","author":"Jones","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2013.03.010_b0180","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1080\/03639040801974337","article-title":"Polyelectrolyte\u2013drug complexes of lambda carrageenan and basic drugs: relevance of particle size and moisture content on compaction and drug release behavior","volume":"34","author":"Bonferoni","year":"2008","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2013.03.010_b0185","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.actbio.2011.09.023","article-title":"Intestinal patches with an immobilized solid-in-oil formulation for oral protein delivery","volume":"8","author":"Toorisaka","year":"2012","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejpb.2013.03.010_b0190","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1023\/A:1015345827091","article-title":"The role of glutathione in the permeation enhancing effect of thiolated polymers","volume":"19","author":"Clausen","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2013.03.010_b0195","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ejpb.2004.03.023","article-title":"Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs","volume":"58","author":"van der Merwe","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641113000994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641113000994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,21]],"date-time":"2019-07-21T03:18:29Z","timestamp":1563679109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641113000994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0939641113000994"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2013.03.010","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}